Infertility Treatment and Breast Cancer Risk in Women with BRCA Pathogenic Variants: A Matched Case-Control Analysis - Summary - MDSpire

Infertility Treatment and Breast Cancer Risk in Women with BRCA Pathogenic Variants: A Matched Case-Control Analysis

  • By

  • Marta Seca

  • Jacek Gronwald

  • Tomasz Huzarski

  • Karen Glass

  • Amber Aeilts

  • Raymond H. Kim

  • Beth Karlan

  • Christian F. Singer

  • Andrea Eisen

  • Nadine Tung

  • Olufunmilayo Olopade

  • Louise Bordeleau

  • Pal Moller

  • William D. Foulkes

  • Susan L. Neuhausen

  • Fergus Couch

  • Tuya Pal

  • Robert Fruscio

  • Cezary Cybulski

  • Jan Lubinski

  • Shana Kim

  • Ping Sun

  • Steven A. Narod

  • Joanne Kotsopoulos

  • November 10, 2025

  • 0 min

Share

Objective:

To assess whether a personal history of infertility or its treatment is associated with an increased risk of breast cancer in women with BRCA pathogenic variants, highlighting the clinical significance of the findings.

Key Findings:
  • No significant association was found between a history of infertility and breast cancer risk in BRCA carriers, which is reassuring given the large sample size of 13,247 women.
Interpretation:

The findings suggest that infertility treatment does not independently increase breast cancer risk in women with BRCA pathogenic variants, providing reassurance for this population and informing clinical decisions.

Limitations:
  • The study relied on self-reported data, which may introduce recall bias, and the exclusion of women with prior cancers may limit generalizability.
Conclusion:

Infertility treatment does not appear to elevate breast cancer risk in women with BRCA mutations, indicating that fertility interventions can be considered without heightened cancer risk concerns, which is crucial for informed decision-making.

Original Source(s)

Infertility Treatment and Breast Cancer Risk in Women with BRCA Pathogenic Variants: A Matched Case-Control Analysis

  • by Marta Seca, Jacek Gronwald, Tomasz Huzarski, Karen Glass, Amber Aeilts, Raymond H. Kim, Beth Karlan, Christian F. Singer, Andrea Eisen, Nadine Tung, Olufunmilayo Olopade, Louise Bordeleau, Pal Moller, William D. Foulkes, Susan L. Neuhausen, Fergus Couch, Tuya Pal, Robert Fruscio, Cezary Cybulski, Jan Lubinski, Shana Kim, Ping Sun, Steven A. Narod, Joanne Kotsopoulos

  • November 10, 2025

Related Content

How much radiologist time can be saved by implementing AI in screen-reading mammograms?

Evaluating the association between upstream perceived individual and neighborhood determinants of health and intensity of breast cancer screening

Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options

Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.